Ramsay, Georgina
Haime, Zoƫ
Crellin, Nadia E
Stansfeld, Jacki L
Priebe, Stefan
Long, Maria
Moncrieff, Joanna
Funding for this research was provided by:
National Institute for Health and Care Research (RP-PG-0514-20004, RP-PG-0514-20004, RP-PG-0514-20004, RP-PG-0514-20004, RP-PG-0514-20004, RP-PG-0514-20004, RP-PG-0514-20004)
Article History
Received: 31 October 2022
Accepted: 3 March 2023
First Online: 29 March 2023
Declarations
:
: Ethical approval for the acceptability study was provided by the East of Scotland Research Ethics Service (REC reference: 15/ES/0163). Ethical approval for the RADAR trial was provided by the Brent Research Ethics Committee (REC reference: 16/LO/1507).All methods were carried out in accordance with relevant guidelines and regulations.Informed consent was obtained from all study participants and/or legal guardians.
: Not applicable.
: JM is chief investigator for a National Institute of Health Research (NIHR) funded trial of antipsychotic reduction versus maintenance treatment, part of the Research into Antipsychotic Discontinuation and Reduction (RADAR) programme. SP is co-chief investigator for the RADAR programme. Other authors have no competing interests to declare.